These can cause dangerous spikes in blood pressure or liver damage
This is a combination product that contains both insulin glargine and lixisenatide, which is a GLP-1 receptor agonist
Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
What GLP-1 receptor agonists actually are GLP-1 receptor agonists are a completely different class of medication
While some studies have shown that chromium supplementation can reduce A1C levels in people with type 2 diabetes, it showed no effect on fasting blood glucose or lipid levels
How Long Do Retatrutide Side Effects Last
